Yesterday, Dec. 2, 2015, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $37.00 to $104,114,531.25.

Highlighted Stocks Traded by Insiders:

QTS Realty (QTS) - FREE Research Report

GA QTS Interholdco, LLC, who is 10% Owner at QTS Realty, sold 2.5 million shares at $41.63 on Dec. 2, 2015. Following this transaction, the 10% Owner owned 1.7 million shares meaning that the stake was reduced by 58.99% with the 2.5 million-share transaction.

The shares most recently traded at $42.35, up $0.73, or 1.71% since the insider transaction. Historical insider transactions for QTS Realty go as follows:

  • 4-Week # shares sold: 1.7 million
  • 12-Week # shares sold: 2.0 million
  • 24-Week # shares sold: 2.0 million

The average volume for QTS Realty has been 333,500 shares per day over the past 30 days. QTS Realty has a market cap of $1.7 billion and is part of the financial sector and real estate industry. Shares are up 25.38% year-to-date as of the close of trading on Wednesday.

QTS Realty Trust, Inc. focuses on the ownership, development, and operation of carrier-neutral data centers in the United States. The company was founded in 2013 and is headquartered in Overland Park, Kansas. The stock currently has a dividend yield of 3%. The company has a P/E ratio of 72.2. Currently, there are 5 analysts who rate QTS Realty a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on QTS - FREE

TheStreet Quant Ratings

rates QTS Realty as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full

QTS Realty Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Parexel International (PRXL) - FREE Research Report

Love Richard L, who is Director at Parexel International, sold 1,330 shares at $68.21 on Dec. 2, 2015. Following this transaction, the Director owned 85,440 shares meaning that the stake was reduced by 1.53% with the 1,330-share transaction.

The shares most recently traded at $66.85, down $1.36, or 2.03% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 3,700
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 3,700
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 5,030

The average volume for Parexel International has been 557,700 shares per day over the past 30 days. Parexel International has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 22.1% year-to-date as of the close of trading on Wednesday.

PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 28.3. Currently, there are 6 analysts who rate Parexel International a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings

rates Parexel International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Parexel International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BankUnited (BKU) - FREE Research Report

Bagnoli Mark, who is Officer of Subsidiary at BankUnited, sold 1,000 shares at $37.41 on Dec. 2, 2015. Following this transaction, the Officer of Subsidiary owned 16,898 shares meaning that the stake was reduced by 5.59% with the 1,000-share transaction.

The shares most recently traded at $37.07, down $0.34, or 0.92% since the insider transaction. Historical insider transactions for BankUnited go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 1,900
  • 24-Week # shares sold: 6,000

The average volume for BankUnited has been 708,600 shares per day over the past 30 days. BankUnited has a market cap of $3.9 billion and is part of the financial sector and banking industry. Shares are up 28.2% year-to-date as of the close of trading on Wednesday.

BankUnited, Inc. operates as the bank holding company for BankUnited, National Association that provides a range of banking products services to commercial and middle-market businesses, and individual customers in the United States. The stock currently has a dividend yield of 2.22%. The company has a P/E ratio of 16.6. Currently, there are 5 analysts who rate BankUnited a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BKU - FREE

TheStreet Quant Ratings

rates BankUnited as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, good cash flow from operations, expanding profit margins and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

BankUnited Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.